Way Less

Way Less operates as a telehealth-focused weight management clinic serving patients throughout Knoxville, Tennessee, with a clinical model centered on GLP-1 receptor agonist therapy. The practice delivers virtual consultations, prescription management, and ongoing monitoring for patients seeking medically supervised weight reduction through semaglutide and tirzepatide protocols. Licensed healthcare providers conduct initial assessments remotely, evaluating patient history, contraindications, and weight loss goals before establishing individualized treatment plans. The clinic's telehealth infrastructure allows Knoxville residents to access GLP-1 therapy without in-person office visits, addressing a significant barrier for patients with scheduling constraints or mobility limitations.

The clinical focus at Way Less centers on two primary GLP-1 medications: semaglutide, a once-weekly injectable that mimics the glucagon-like peptide-1 hormone to regulate appetite and glucose metabolism, and tirzepatide, a dual GIP/GLP-1 receptor agonist that activates both incretin pathways for enhanced metabolic effects. Providers prescribe these medications following FDA-approved dosing escalation schedules, typically starting patients at lower doses and gradually increasing based on tolerance and response. The clinic sources medications through licensed compounding pharmacies when brand-name formulations face supply constraints, ensuring treatment continuity for active patients. Way Less providers adjust dosing protocols based on individual patient responses, side effect profiles, and weight loss velocity, with virtual check-ins scheduled at regular intervals throughout the treatment course.

The provider team at Way Less includes licensed nurse practitioners and physicians who conduct all patient consultations, prescription authorizations, and medical oversight remotely via HIPAA-compliant video platforms. Each provider reviews comprehensive patient intake forms that document medical history, current medications, previous weight loss attempts, and comorbid conditions such as type 2 diabetes, hypertension, or sleep apnea. Providers assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disorders before initiating GLP-1 therapy. The clinical team monitors patients for common side effects including nausea, constipation, and injection site reactions, adjusting protocols when adverse effects interfere with treatment adherence. Providers also coordinate with patients' primary care physicians when GLP-1 therapy requires adjustments to existing diabetes or blood pressure medications.

Patients beginning treatment with Way Less complete an online intake process that includes medical questionnaire submission, insurance verification when applicable, and scheduling of an initial video consultation. During the first appointment, providers discuss realistic weight loss expectations, review proper injection techniques for subcutaneous administration, and establish monitoring schedules that typically include monthly virtual check-ins. The clinic provides educational resources on managing common side effects, maintaining adequate hydration, and adjusting dietary patterns to complement GLP-1 therapy's appetite-suppressing effects. Patients receive prescriptions electronically, with medications shipped directly to their Knoxville addresses from partner pharmacies. The remote monitoring model includes regular weight tracking, side effect reporting through patient portals, and provider availability for questions between scheduled appointments. Way Less does not require long-term contracts, allowing patients to discontinue treatment after achieving goals or if side effects prove intolerable.

The telehealth delivery model distinguishes Way Less from traditional weight management clinics in the Knoxville area by eliminating travel time and waiting room visits while maintaining clinical oversight throughout treatment. The practice accepts various payment structures including insurance billing for patients with coverage for obesity treatment and self-pay options for those without pharmaceutical benefits for weight management. Prescription costs vary based on medication choice, dosing level, and whether patients access brand-name or compounded formulations. The clinic's virtual platform accommodates patients across Tennessee who meet licensing requirements for telehealth prescribing, though the primary patient base resides in Knoxville and surrounding Knox County communities. Way Less maintains a 4.5-star rating across 22 Google reviews, with patient feedback frequently noting the convenience of virtual appointments and responsiveness of the provider team to dosing questions and side effect management.